Analyst Activity – Cantor Fitzgerald Reiterates Overweight on Arena Pharmaceuticals (NASDAQ:ARNA)

12

Analyst Ratings For Arena Pharmaceuticals (NASDAQ:ARNA)

Today, Cantor Fitzgerald reiterated its Overweight rating on Arena Pharmaceuticals (NASDAQ:ARNA) with a price target of $37.00.

There are 3 hold ratings, 6 buy ratings on the stock.

The current consensus rating on Arena Pharmaceuticals (NASDAQ:ARNA) is Buy (Score: 2.67) with a consensus target price of $38.83 per share, a potential 59.94% upside.

Some recent analyst ratings include

  • 7/17/2017-Cantor Fitzgerald Reiterated Rating of Overweight.
  • 7/12/2017-Wells Fargo & Company Reiterated Rating of Market Perform.
  • 7/7/2017-JMP Securities Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
  • 3/16/2017-FBR & Co Reiterated Rating of Outperform.
  • 1/7/2017-Needham & Company LLC Reiterated Rating of Hold.

Dividend information for Arena Pharmaceuticals (NASDAQ:ARNA)

.

  • On 5/12/2017 Amit Munshi, Insider, bought 25,000 with an average share price of $1.19 per share and the total transaction amounting to $29,750.00. View SEC Filing
  • On 4/26/2017 Amit Munshi, Insider, bought 50,000 with an average share price of $1.41 per share and the total transaction amounting to $70,500.00. View SEC Filing
  • On 6/13/2016 Christine Anna White, Director, sold 18,728 with an average share price of $1.99 per share and the total transaction amounting to $37,268.72. View SEC Filing
  • On 3/30/2015 Randall E Woods, Director, sold 76,268 with an average share price of $4.49 per share and the total transaction amounting to $342,443.32. View SEC Filing
  • On 3/17/2015 Steven W Spector, EVP, sold 70,000 with an average share price of $5.00 per share and the total transaction amounting to $350,000.00. View SEC Filing
  • On 1/8/2015 Steven W Spector, EVP, sold 45,000 with an average share price of $6.26 per share and the total transaction amounting to $281,700.00. View SEC Filing
  • On 1/7/2015 William R Shanahan Jr, SVP, sold 50,000 with an average share price of $5.49 per share and the total transaction amounting to $274,500.00. View SEC Filing

Recent Trading Activity for Arena Pharmaceuticals (NASDAQ:ARNA)
Shares of Arena Pharmaceuticals closed the previous trading session at 24.30 up +0.02 0.08% with 1,180,562 shares trading hands.

An ad to help with our costs